Microbicides safe during pregnancy – study
Study participants applied a single dose of tenofovir gel two hours before birth by cesarean section.
Dr Richard Beigi of the University Pittsburgh and Magee-Women’s Hospital, who headed the study for the Microbicide Trials Network (MTN), said it microbicides could be an integral part in the prevention arsenal since there was evidence that condom use decreased during pregnancy.
Women in the study were discouraged from falling pregnant while participating in the trial and encouraged to use birth control and condoms.
Tenofovir, a widely used antiretroviral, was one of the compounds used in the candidate microbicide.
Previous research has shown that tenofovir is safe and effective for use in pregnant women.
However, earlier research showed that oral ingestion of tenofovir led to small amounts of the drug being passed onto the baby when given to women to prevent HIV transmission to their babies during birth.
The microbicide study showed that the levels of tenofovir found in the umbilical cord were 40 times lower than levels found when the drug was applied orally.
The mothers and babies suffered no serious side effects due to the gel, researchers said.
Beigi said the findings supported continuing studies that used tenofovir gel among pregnant women.
Author
-
Health-e News is South Africa's dedicated health news service and home to OurHealth citizen journalism. Follow us on Twitter @HealtheNews
View all posts
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
-
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
-
You must include all of the links from our story, including our newsletter sign up link.
-
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
-
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
-
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
-
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
-
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Microbicides safe during pregnancy – study
by Health-e News, Health-e News
May 24, 2010